Query author contributions in Reactome
Reactome depends on collaboration between our curation team and outside experts to assemble and peer-review its pathway modules. The integration of ORCID within Reactome enables us to meet a key challenge with authoring, curating and reviewing biological information by incentivizing and crediting the external experts that contribute their expertise and time to the Reactome curation process. More information is available at ORCID and Reactome.
If you have an ORCID ID that is not listed on this page, please forward this information to us and we will update your Reactome pathway records.
Details on Person Botulinum toxin type E light chain (botE LC), in the cytosol...
| Class:Id | Summation:201308 |
|---|---|
| _displayName | Botulinum toxin type E light chain (botE LC), in the cytosol... |
| _timestamp | 2020-10-08 21:59:58 |
| created | [InstanceEdit:201316] Gopinathrao, G, 2007-08-03 18:19:30 |
| modified | [InstanceEdit:5263577] D'Eustachio, Peter, 2014-02-11 [InstanceEdit:5602263] D'Eustachio, Peter, 2014-06-20 [InstanceEdit:9704403] D'Eustachio, Peter, 2020-10-08 |
| text | Botulinum toxin type E light chain (botE LC), in the cytosol of a target cell, catalyzes the removal of a carboxyterminal peptide from synaptosomal-associated protein 25 (SNAP25). botE LC is a zinc metalloprotease (Binz et al. 1994; Schiavo et al. 1993; Vaidyanathan et al. 1999). SNAP25 is associated with the cytosolic face of the target cell plasma membrane where it forms part of a complex required for synaptic vesicle docking and exocytosis. Its cleavage by botulinum toxin blocks synaptic vesicle fusion with the plasma membrane and neurotransmitter release and in vivo leads to a long lasting flaccid paralysis (Sudhof et al, 1993; Sudhof 2004). |
| (summation) | [Reaction:194800] botE LC cleaves target cell SNAP25 [Homo sapiens] |
| [Change default viewing format] | |
No pathways have been reviewed or authored by Botulinum toxin type E light chain (botE LC), in the cytosol... (201308)
